Naoki Mori Selected Research

Naoki Mori Research Topics

Disease

53	Neoplasms (Cancer) 01/2022 - 02/2002
38	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2022 - 02/2002
28	T-Cell Leukemia (Leukemia, T Cell) 01/2022 - 02/2002
17	Infections 08/2018 - 05/2003
10	Neoplasm Metastasis (Metastasis) 10/2020 - 02/2002
10	Lymphoma (Lymphomas) 01/2019 - 01/2002
9	Carcinogenesis 07/2010 - 01/2003
5	Leukemia 03/2021 - 01/2006
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 06/2002
5	Prostatic Neoplasms (Prostate Cancer) 04/2014 - 08/2004
5	Hodgkin Disease (Hodgkin's Disease) 12/2012 - 03/2006
5	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2012 - 01/2006
4	Fatigue 10/2021 - 04/2006
4	Primary Effusion Lymphoma 01/2021 - 01/2011
4	Carcinoma (Carcinomatosis) 11/2015 - 09/2009
4	Retinal Degeneration 03/2007 - 02/2002
3	Melanoma (Melanoma, Malignant) 10/2021 - 04/2003
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2021 - 11/2007
3	Acquired Immunodeficiency Syndrome (AIDS) 11/2020 - 01/2006
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2020 - 01/2005
3	Atrial Fibrillation 10/2019 - 08/2013
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 04/2018 - 12/2008
3	Adenocarcinoma 01/2017 - 06/2002
3	Fever (Fevers) 03/2015 - 07/2011
3	Osteosarcoma (Osteogenic Sarcoma) 10/2013 - 08/2011
3	Tetraploidy 04/2013 - 10/2004
3	Hepatocellular Carcinoma (Hepatoma) 05/2012 - 03/2006
3	T-Cell Lymphoma (Lymphoma, T Cell) 07/2011 - 01/2003
3	Renal Cell Carcinoma (Grawitz Tumor) 06/2011 - 06/2009
2	Stroke (Strokes) 02/2022 - 01/2021
2	Esophageal Squamous Cell Carcinoma 08/2021 - 10/2020
2	Hemorrhage 10/2019 - 01/2016
2	Ascites 11/2017 - 09/2013
2	Myocardial Infarction 01/2017 - 02/2014
2	Acute Coronary Syndrome 01/2017 - 02/2014
2	Thrombosis (Thrombus) 01/2017 - 01/2016
2	Carcinoma in Situ 04/2014 - 04/2013
2	Fibrosis (Cirrhosis) 10/2013 - 05/2012
2	Inflammation (Inflammations) 08/2013 - 02/2009
2	Liver Diseases (Liver Disease) 05/2012 - 01/2009
2	Pancreatitis 01/2012 - 06/2011
2	Lung Diseases (Lung Disease) 12/2011 - 09/2008

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 08/2017 - 02/2002
17	NF-kappa B (NF-kB)IBA 01/2010 - 09/2002
9	DNA (Deoxyribonucleic Acid)IBA 08/2017 - 02/2003
6	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 03/2004
6	Messenger RNA (mRNA)IBA 01/2022 - 01/2003
6	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2021 - 03/2006
6	fucoidanIBA 11/2017 - 01/2005
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2006
5	Phosphotransferases (Kinase)IBA 12/2020 - 08/2017
5	LigandsIBA 12/2015 - 02/2005
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2021 - 07/2007
4	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 07/2007
4	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 07/2007
4	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2007
4	Polysaccharides (Glycans)IBA 11/2017 - 01/2005
4	fucoxanthinolIBA 10/2013 - 12/2008
4	fucoxanthinIBA 10/2013 - 12/2008
3	Rituximab (Mabthera)FDA Link 01/2021 - 09/2011
3	Janus KinasesIBA 10/2018 - 04/2006
3	CytokinesIBA 01/2012 - 04/2006
3	Matrix Metalloproteinases (MMPs)IBA 08/2011 - 02/2002
3	Aurora Kinase BIBA 05/2011 - 05/2010
3	NF-KappaB Inhibitor alphaIBA 05/2007 - 02/2006
3	CurcuminIBA 04/2006 - 02/2006
2	AntigensIBA 10/2021 - 05/2003
2	LipidsIBA 08/2021 - 10/2013
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2021 - 07/2011
2	ArtesunateIBA 01/2021 - 04/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2015
2	Histone Deacetylase InhibitorsIBA 12/2020 - 05/2004
2	AnticoagulantsIBA 10/2019 - 01/2016
2	R-CHOP protocolIBA 01/2019 - 09/2011
2	Hormones (Hormone)IBA 03/2018 - 01/2012
2	Interleukin-2 (IL2)IBA 08/2017 - 07/2009
2	C-Reactive ProteinIBA 11/2015 - 08/2013
2	EnzymesIBA 03/2015 - 07/2008
2	Estrogens (Estrogen)FDA Link 04/2014 - 04/2004
2	hippuristanolIBA 09/2013 - 03/2011
2	InterferonsIBA 09/2013 - 06/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2013 - 03/2005
2	Factor VIII (Coagulation Factor VIII)IBA 01/2012 - 07/2007
2	Biological ProductsIBA 12/2011 - 01/2009
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2011 - 03/2006

Therapy/Procedure

32	Therapeutics 01/2022 - 09/2004
11	Drug Therapy (Chemotherapy) 01/2018 - 01/2006
5	Radiotherapy 10/2020 - 04/2007
4	Esophagectomy 10/2020 - 01/2005
4	Cystectomy 01/2018 - 01/2011
4	Prostatectomy (Retropubic Prostatectomy) 09/2004 - 10/2003
3	Activities of Daily Living (ADL) 01/2022 - 01/2021
3	Aftercare (After-Treatment) 10/2020 - 05/2012
3	Nephrectomy 08/2009 - 06/2009
2	Immunotherapy 08/2021 - 04/2013
2	Catheters 01/2017 - 04/2013
2	Urinary Diversion (Ileal Conduit) 01/2017 - 04/2014
2	Stents 01/2017 - 01/2016
2	Adjuvant Chemotherapy 11/2015 - 09/2010
2	Pancreaticoduodenectomy 03/2015 - 08/2012